Last updated on April 24, 2014 at 21:24 EDT

Dr. Ronald D. Alvarez Elected 44th President of the Society of Gynecologic Oncology

April 3, 2012

CHICAGO, April 3, 2012 /PRNewswire-USNewswire/ — Ronald D. Alvarez, MD, Professor and Director of the Division of Gynecologic Oncology at the University of Alabama at Birmingham (UAB), has been elected the 44th President of the Society of Gynecologic Oncology (SGO) at its 43rd Annual Meeting on Women’s Cancer held March 24-27, 2012, in Austin, TX.

“We are in the midst of evolutionary times and our members need to be prepared for the changes coming with health care reform,” states Dr. Alvarez. “Our members need to feel empowered to be the best providers of high quality, cost effective prevention and treatment to women at risk for or diagnosed with gynecologic cancer.”

Dr. Alvarez received his BS in Zoology from Louisiana State University in 1979 and his MD from Louisiana State University Medical Center in 1983. His postgraduate training included a residency in Obstetrics and Gynecology (1987) and fellowship in Gynecologic Oncology (1990), both completed at UAB.

After completing his training, he remained on the faculty of the UAB Department of Obstetrics and Gynecology, where he currently serves as Director of the Division of Gynecologic Oncology and Vice-Chairman of the Department of Obstetrics and Gynecology; he also holds the Ellen Gregg Shook Culverhouse Chair.

His long-term research interests have included the development of novel therapeutics for ovarian cancer and new screening and prevention strategies for cervical cancer. He has been the recipient of several NCI and other industry funded grants in support of his research in gene therapeutics for ovarian cancer and he is currently a coprincipal investigator in cervical neoplasm vaccine projects included in the Johns Hopkins/UAB Cervical SPORE.

Dr. Alvarez has published over 200 articles in various peer-reviewed journals and he is on the editorial board of Gynecologic Oncology. He currently serves as a Board Member of the Gynecologic Oncology Group and is cochair of its Protocol Development Committee. He is on the Gynecologic Oncology Division of the American Board of Obstetrics and Gynecology and has served on study sections for the NCI and the Department of Defense Ovarian Cancer Research Program. He has also served on the Executive Committee of the Foundation for Women’s Cancer.

About the SGO
The Society of Gynecologic Oncology (SGO) is a national medical specialty organization of physicians and allied healthcare professionals who are trained in the comprehensive management of women with malignancies of the reproductive tract. Its purpose is to improve the care of women with gynecologic cancer by encouraging research, disseminating knowledge that will raise the standards of practice in the prevention and treatment of gynecologic malignancies, and cooperating with other organizations interested in women’s health care, oncology and related fields. The Society’s membership, totaling more than 1,600, is primarily comprised of gynecologic oncologists, as well as other related medical specialists including medical oncologists, radiation oncologists, nurses, social workers and pathologists. SGO members provide multidisciplinary cancer treatment including chemotherapy, radiation therapy, surgery and supportive care. More information on the SGO can be found at www.sgo.org.

For more information, please contact:
Jessica Oldham

Greg Leaf

SOURCE Society of Gynecologic Oncology

Source: PR Newswire